Counterfeiting

New York Pharmaceutical Distributor Caught with Counterfeit Avastin

The FDA is warning physicians to be on the lookout for fake versions of Roche’s cancer drug.

The Food and Drug Administration is warning doctors about another counterfeit version of the cancer drug Avastin distributed in the U.S., the third case involving the best-selling Roche drug in the past year.

No votes yet

New York Pharmaceutical Distributor Caught with Counterfeit Avastin

The FDA is warning physicians to be on the look out for fake versions of Roche’s cancer drug.

The Food and Drug Administration is warning doctors about another counterfeit version of the cancer drug Avastin distributed in the U.S., the third case involving the best-selling Roche drug in the past year.

No votes yet

Pharma, Personal Care Products Among Most Counterfeited in U.S.

About $83 million worth of counterfeited pharmaceutical packaging, drugs and personal care items were seized by U.S. Customs last year.

Approximately $1.26 billion worth of counterfeit goods originating overseas were seized by the U.S. Customs and Border Protection (CBP) in 2012. Each seizure averaged $10,450 worth of counterfeit goods. The value and the number of seizures changes dramatically each year due to the products sold and the success of CBP operations. The value of handbags and wallets seized in 2012 rose 142% compared with the previous year.

Your rating: None Average: 5 (2 votes)

FDA: Be On the Lookout for Counterfeit Adderall Tablets, Teva Pharmaceutical Industries

The agency states crooks are selling tablets labeled as the ADHD drug but that actually contain tramadol and acetaminophen.

The Food and Drug Administration is warning consumers that a counterfeit version of the attention deficit hyperactivity disorder drug Adderall is being sold over the Internet.

No votes yet

FDA Uncovers More Counterfeit Cancer Drugs

A batch of the cancer treatment Avastin shipped from the U.K. to the U.S. has been determined to be fake.

A new batch of counterfeit Avastin discovered in the United States was shipped from

Combating Counterfeits

The pharma industry is working toward establishing the ideal anticounterfeiting system, combining authentication tools and track-and-trace capabilities to serialize at the unit level, for every drug.

By Marie Redding
Freelance Writer

It’s increasingly difficult—even for the experts—to tell the difference between a counterfeit drug and the real thing. Consumers feel they have no sure way of knowing if they’re getting duped. They may even ingest a harmful ingredient a counterfeiter has used to make a fake pill—like highway paint, floor wax, and boric acid—according to a CBS news report.

No votes yet

Tech Beats Security Breach

There is a growing need for creative out-of-the-box technologies that prevent a rift in patient safety while keeping a company’s investments and reputation in good standing. Counterfeiting, diversion, the resale of expired products, and complexities within the supply chain are forcing the healthcare industry to seek ahead-of-the-curve security packaging.

No votes yet

United Front Forms Against Counterfeits

A cooperative agreement between the U.S. Food and Drug Administration and the World Health Organization aims to construct a sound evidence base on counterfeit, falsified, and substandard medicines. The recent project proposal was developed by WHO in response to a call for a proposal on counterfeit medicines from FDA, but the two organizations will work closely together on the project.

No votes yet

NanoGuardian Bolsters Defenses Against Counterfeiting and Illegal Diversion

As evidence of its continued commitment to the fight against counterfeiting and illegal diversion, NanoGuardian forges ahead with several business moves in 2010. Among some of the most prominent efforts are a global collaboration with Capsugel, the extension of NanoEncryption technology to cover single-use vial caps and pre-filled syringes, and a partnership agreement with Altegrity Risk. NanoGuardian, a division of NanoInk, delivers brand protection solutions to defend against illegal diversion and counterfeiting.

Can FDA Cure Two Ills with Just One Bill?

Senator Michael Bennet, D-CO, has had enough of drug recalls. This week Bennet introduced Senate Bill S. 3690, the Drug Safety and Accountability Act of 2010, to increase FDA's authority over drug quality and safety.

No votes yet
Syndicate content